Takayasu arteritis (TAK) is a chronic, large-vessel systemic vasculitis, 1 which affects large arteries, such as the aorta and its major branches and the pulmonary arteries. TAK mainly occurs in young adults, and may even affect children. 2 This disease occurs in both genders, but is more common in women during the second and third decades. TAK is distributed globally, with a greater prevalence in Asia. The variation in incidence and age of diagnosis among different ethnic groups is considerable. 3 In the acute phase of TAK, intima thickens with fibroblasts due to inflammation and mucopolysaccharide deposition. In the chronic phase, vascular fibrosis, vascular stenosis and occlusion, aneurysmal dilation occur in the aorta and major branches, which leads to hypertension, renal artery stenosis, pulmonary hypertension and congestive heart failure. 3 Interleukin (IL)-10 is a prototypical anti-inflammatory cytokine which plays a role in the maintenance and restoration of immunological homeostasis. Also, it can enhance the immune responses. 4